 |
|
 |
 |
| |
Paul H. Toffel, M.D.
Committee Chairman
It is again with great pride and affection that I review the Corporate Affiliates Research Grant Program of the American Rhinologic Society because it parallels the wonderful growth and spirit of our organization since the mid-90's.
The idea for corporations to sponsor pure unrestricted research grants in Rhinology was seeded by our devoted Treasurer, Dr. David Kennedy in 1995, during the tenure of President Vijay Anand. Our Board of Directors discussed and formed this new initiative, which has brought approximately $450,000 to our young faculty investigators and residents in the form of $25,000 and $8,000 annual grants.
Through the presidential terms of Drs. Dale Rice, Mike Benninger, Bill Panje, Charlie Gross, Fred Kuhn, myself, Don Lanza, Jim Hadley, Joe Jacobs and Mike Sillers, this program has allowed over two dozen of our young, bright minds to have unfettered funds for direct basic science research in all aspects of Rhinology. The program has been elevated by its administration via the CORE (Combined Otolaryngologic Research Entity) initiative of our affiliated umbrella societies, and the ARS can be proud of awarding approximately 10% of all research dollars granted via CORE the past decade.
None of this would be possible without the synergies we have with our wonderful instrument and pharmaceutical corporate thought-leaders who recognize the value of working with our society's research arm with no restrictions upon our use of the funds. We have fostered, and continue to foster, wonderful relationships between industry and our society for the greater good of our rhinology patients.
The research programs continue to gain support from our corporate sponsors, who have the opportunity to meet with our society's though-leaders at functions we sponsor for the corporate friends each year at our spring meeting.
The society is always grateful for educational grants from industry which help our endeavors, and these are always recognized in our meetings and publications, but we are particularly grateful to these corporate sponsors who place pure research for the benefit of our medical and surgical patients foremost. It has continually been an honor for me to serve the society as Chairman of this Committee. I want to thank my committee members, Drs. Nicolas Busaba, Peter Catalano, Alexander Chiu, Jay Dutton, James Hadley, Joseph Han, Clark Huang and Robert Kern, for their help in suggesting contacts to foster these lofty goals.
|
|
|
|
|
